Suchergebnisse - "Fink-Jensen, Anders"

PubPharm (257)

1

Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department : A 26-week open-label feasibility study

enthalten in: Acta psychiatrica Scandinavica | 2024

von Sass, M. | Christensen, A. | Christensen, M. | +9

2

Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline : A post hoc subgroup analysis

enthalten in: Obesity (Silver Spring, Md.) | 2024

von Kushner, R. | Fink-Jensen, A. | Frenkel, O. | +4

3

Virtual reality-assisted cognitive behavioral therapy for patients with alcohol use disorder : a randomized feasibility study

enthalten in: Frontiers in psychiatry | 2024

von Thaysen-Petersen, D. | Hammerum, S. | Vissing, A. | +4

4

GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders

enthalten in: Nature medicine | 2023

von Leggio, L. | Hendershot, C. | Farokhnia, M. | +4

5

The effectiveness of oxytocin for treating substance use disorders:A systematic review of randomized placebo-controlled trials

enthalten in: Neuroscience and biobehavioral reviews | 2023

von Mellentin, A. | Finn, S. | Skøt, L. | +4

6

The use of classic psychedelics among adults : a Danish online survey study

enthalten in: Nordic journal of psychiatry | 2023

von Søgaard Juul, T. | Ebbesen Jensen, M. | Fink-Jensen, A.

7

Virtual reality-assisted cognitive behavioural therapy for outpatients with alcohol use disorder (CRAVR) : a protocol for a randomised controlled trial

enthalten in: BMJ open | 2023

von Thaysen-Petersen, D. | Hammerum, S. | Vissing, A. | +7

8

Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder : study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)

enthalten in: BMJ open | 2023

von Sass, M. | Danielsen, A. | Köhler-Forsberg, O. | +11

9

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series

enthalten in: Therapeutic advances in psychopharmacology | 2023

von Prasad, F. | De, R. | Korann, V. | +9

10

Use of GLP-1 receptor agonists and subsequent risk of alcohol-related events. A nationwide register-based cohort and self-controlled case series study

enthalten in: Basic & clinical pharmacology & toxicology | 2022

von Wium-Andersen, I. | Wium-Andersen, M. | Fink-Jensen, A. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]